Pulse Biosciences, Inc.
PLSE
$17.74
$0.855.03%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 51.62% | 32.40% | 7.40% | -19.07% | -39.26% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.11% | 22.00% | -0.91% | -11.81% | -25.84% |
| Operating Income | -29.11% | -21.98% | 0.93% | 11.36% | 24.95% |
| Income Before Tax | -26.95% | -16.87% | 6.24% | 16.63% | 27.85% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -26.95% | -16.87% | 6.24% | 16.63% | 27.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -26.95% | -16.87% | 6.24% | 16.63% | 27.85% |
| EBIT | -29.11% | -21.98% | 0.93% | 11.36% | 24.95% |
| EBITDA | -30.00% | -22.80% | 0.78% | 11.41% | 25.28% |
| EPS Basic | -2.64% | 11.30% | 35.08% | 44.32% | 49.95% |
| Normalized Basic EPS | -2.62% | 10.80% | 34.81% | 44.13% | 49.81% |
| EPS Diluted | -2.64% | 11.30% | 35.08% | 44.32% | 49.95% |
| Normalized Diluted EPS | -2.62% | 10.80% | 34.81% | 44.13% | 49.81% |
| Average Basic Shares Outstanding | 20.51% | 28.67% | 42.07% | 48.80% | 44.07% |
| Average Diluted Shares Outstanding | 20.51% | 28.67% | 42.07% | 48.80% | 44.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |